Scleroderma

June 11, 2015November 6, 2015

Breakthrough Therapy Status Granted to Roche’s SSc Treatment

News, Scleroderma

Roche was recently granted breakthrough therapy designation (BTD) by the U.S. Food and Drug Administration (FDA) for its combined treatment ACTEMRA/RoACTEMRA (tocilizumab) for systemic sclerosis (SSc). The status was awarded based on successful ... Read more

June 5, 2015November 6, 2015

Accuracy of High Resolution Computed Tomography, Lung Function Tests in SSc Evaluated in New Study

News, Scleroderma

In a recent study published in the journal Arthritis & Rheumatology, researchers found that high resolution computed tomography (HRCT) predicts fibrosis development, rate of fibrosis progression and pulmonary function decline ... Read more

March 24, 2015November 6, 2015

Scleroderma Patients Have Lower Survival Rates Even with Early Lung Cancer Diagnosis

News, Scleroderma

In a recent study entitled “Early stage lung cancer detection in systemic sclerosis does not portend survival benefit: a cross sectional study,” the authors characterize lung cancer profiles in Systemic ... Read more

March 17, 2015November 6, 2015

Serum Progranulin a Potential Biomarker for Interstitial Lung Disease-associated Dermatomyositis

News, Scleroderma

A recent Japanese study proposed that high serum progranulin levels may be used as biomarkers in dermatomyositis and interstitial lung diseases. The study entitled “Serum progranulin levels are elevated in ... Read more

March 11, 2015November 6, 2015

Corbus Pharmaceuticals’ IND Receives Clearance From FDA To Start Phase 2 Trials For Scleroderma

News, Scleroderma

Corbus Pharmaceuticals recently announced that the company’s Investigational New Drug (IND) application to the United States Food and Drug Administration (FDA) is now open and has received clearance to initiate a Phase 2 clinical ... Read more

February 13, 2015November 6, 2015

Apricus Biosciences Announces Patent Award for RayVa Investigational Scleroderma Therapy

Scleroderma

Last October, Apricus Biosciences, Inc., a biopharmaceutical company advancing innovative medicines in urology and rheumatology, announced that The United States Patent and Trademark Office (USPTO) had issued a Notice of ... Read more

February 4, 2015November 6, 2015

Corbus Pharmaceuticals To Present on SSc, CF Therapy at 17th Annual BIO CEO & Investor Conference in February

News, Scleroderma

Corbus Pharmaceuticals Holdings, Inc., an emerging drug development company working on the advancement and marketing of its lead product candidate Resunab to address life-threatening and rare fibrotic and inflammatory diseases, announced recently that it ... Read more

January 26, 2015November 6, 2015

High Systolic Pulmonary Artery Pressure is a Red Flag in Systemic Sclerosis Patients

News, Scleroderma

A recent study published in the journal Rheumatology revealed that a high systolic pulmonary artery pressure (sPAP) can elevate the mortality risk in individuals with systemic sclerosis (SSc). SSc is a ... Read more

December 22, 2014November 6, 2015

Cytori To Host Informational Session On Scleroderma, STAR Pivotal Trial

News, Scleroderma

On January 14, 2015, Cytori Therapeutics, Inc. will host an information session about advances in scleroderma research and the company’s STAR pivotal trial for its own experimental Scleroderma therapy. This session will take ... Read more

December 11, 2014November 6, 2015

‘STAR’ Trial In Scleroderma By Cytori Therapeutics Receives FDA Conditional Approval

News, Scleroderma

Cytori Therapeutics, Inc. received a conditional investigational device exemption (IDE) approval from the Food and Drug Administration (FDA) to launch the STAR trial in order to evaluate Cytori Cell Therapy as a ... Read more